Clinical Trial Update: Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing left atrial appendage closure with novel anticoagulation agents in atrial fibrillation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED